Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 7.56B 1.12B 978M 906M 834M 1.58B 107B 1.61B 10.8B 4.24B 52.43B 4.19B 4.1B 181B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 5.07B 748M 656M 608M 559M 1.06B 71.58B 1.08B 7.24B 2.84B 35.15B 2.81B 2.75B 121B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day+3.35%
1 week+3.35%
Current month+15.52%
1 month+4.10%
3 months+5.71%
6 months-14.24%
Current year-12.32%
1 week 12.2
Extreme 12.2
13.12
1 month 11.04
Extreme 11.04
13.12
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
17.17
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 44 07/01/2019
Director of Finance/CFO 49 06/12/2021
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 26/03/2014
Director/Board Member 64 26/09/2017
Director/Board Member 44 26/09/2017
Date Insider Type Main position Quantity % Market Cap.
17/07/24Buy 500 0.0001%
22/01/20Sell

Director

246,300 0.0462%
01/01/20Sell 1,095,000 0.2053%
Change 5-day change 1-year change 3-year change Capi.($)
+3.35%+3.35%-19.31%-42.62% 1.08B
+1.90%+1.82%-11.27%-6.90% 12.85B
+3.59%+5.01%-31.29%-52.81% 4.79B
+4.15%+3.48%-3.60%-5.91% 4.4B
+6.19%+5.44%+10.39%-32.89% 3.82B
+3.72%-3.85%+15.82%-4.31% 3.68B
+2.71%+9.52%-6.14%-8.78% 3.26B
+2.13%+2.71%-9.27%+6.52% 3.1B
+1.03%+2.29%-7.29%-21.36% 2.41B
+4.33%+9.31%-1.05%+52.08% 1.8B
Average +3.31%+3.95%-6.30%-11.70% 4.12B
Weighted average by Cap. +3.07%+3.56%-7.32%-12.65%

Financials

2024 2025
Net sales 3.38B 498M 437M 405M 372M 704M 47.67B 718M 4.82B 1.89B 23.41B 1.87B 1.83B 80.84B 2.32B 342M 300M 278M 256M 483M 32.72B 493M 3.31B 1.3B 16.07B 1.28B 1.26B 55.49B
Net income 492M 72.57M 63.65M 58.95M 54.24M 103M 6.95B 105M 703M 276M 3.41B 272M 267M 11.78B -258M -38.02M -33.35M -30.89M -28.42M -53.76M -3.64B -54.81M -368M -144M -1.79B -143M -140M -6.17B
Net Debt -2.29B -338M -296M -274M -252M -477M -32.32B -487M -3.27B -1.28B -15.87B -1.27B -1.24B -54.81B -2.49B -368M -322M -299M -275M -520M -35.18B -530M -3.56B -1.4B -17.28B -1.38B -1.35B -59.66B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
13/07/26 CN¥12.95 +3.35% 12,057,800
10/07/26 CN¥12.53 +0.97% 5,586,867
09/07/26 CN¥12.41 -0.96% 5,959,081
08/07/26 CN¥12.53 +0.89% 5,369,673
07/07/26 CN¥12.42 -2.59% 5,705,226

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock